Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs

NCT04840082 | Completed

• 1 other identifier: 21015626
• Study Type: interventional
• Target: 109
• Locations: 1 country
• Sites: 1

Brief Summary

This study aim to explore the optimal swap insertion length for mid-turbinate and nasopharyngeal samples. Our clinical trial took place at a Covid-19 test center in Copenhagen. Participants consisted of voluntary citizens who were at the test center for a nasopharyngeal antigen quicktest. An endoscopic examination was performed simultaneous with the swap to measure the length from the vestibulum nasi to the posterior wall of the nasopharynx and the mid-turbinate.

Conditions

Covid19

Outcome Measures

Primary Outcomes (2)

• Length from the vestibulum nasi to the posterior wall of the nasopharynx.

  Endoscopic measurement of the length from the vestibulum nasi to the posterior wall of the nasopharynx.

  From inclusion at the testcenter until the COVID-19 testing was completed.

• Length from the vestibulum nasi to the mid-turbinate.

  Endoscopic measurement of the length from the vestibulum nasi to the mid-turbinate.

  From inclusion at the testcenter until the endoscopic examination was completed

Study Arms (1)

Collecting of Clinical Specimens for COVID-19 Testing

EXPERIMENTAL

Nasopharyngeal swab is performed on all participants to collect specimens for Rapid antigen COVID-19 Testing

Diagnostic Test: Nasopharyngeal swab for COVID-19 testing

Interventions

Nasopharyngeal swab for COVID-19 testing DIAGNOSTIC_TEST

A nasopharyngeal swab was performed endoscopically video guided to measure the actual length from to the mid turbinate and the posterior nasopharyngeal wall

Collecting of Clinical Specimens for COVID-19 Testing

Eligibility Criteria

• Age: 16 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Referred for COVID-19 testing

You may not qualify if:

• Nose patology

Sponsors & Collaborators

• Rigshospitalet, Denmark: lead

Study Sites (1)

Rigshospitalet

Copenhagen, Copenhagen East, 2100, Denmark

Location

MeSH Terms

Conditions

COVID-19

Interventions

COVID-19 Testing

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD, PhD, Ass. Prof

Study Record Dates

• First Submitted: April 6, 2021
• First Posted: April 9, 2021
• Study Start: March 7, 2021
• Primary Completion: March 8, 2021
• Study Completion: March 8, 2021
• Last Updated: April 9, 2021

Record last verified: 2021-04

Locations

DK (1)